€214,697
▼ Sales (10 ops.)
Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Nayak Sanjay. Insider active across 2 companies, notably Ocular Therapeutix, INC. Cumulatively, 13 reports have been published. Split: 0 buy · 10 sells. Total volume traded: €215k. History available since 22 February 2024. The latest transaction was disclosed on 24 August 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Nayak Sanjay
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
1,897 shares@ US$10.78Common StockSEC:0001104659-26-101671:0
1,759 shares@ US$8.289.4% of flowCommon StockSEC:0001104659-26-019802:0
10,348 shares@ US$9.0460.5% of flowCommon StockSEC:0001104659-26-016667:0
64,900 shares0Common StockSEC:0001104659-26-001292:0
1,878 shares@ US$12.0450.1% of flowCommon StockSEC:0001104659-25-116425:0
1,885 shares@ US$12.04100.0% of flowCommon StockSEC:0001104659-25-084116:0
1,862 shares@ US$7.178.3% of flowCommon StockSEC:0001104659-25-053094:0
1,895 shares@ US$6.8422.5% of flowCommon StockSEC:0001104659-25-017562:0
111,000 shares0Common StockSEC:0001104659-25-013153:0
1,814 shares@ US$9.0028.3% of flowCommon StockSEC:0001104659-24-123410:0
1,832 shares@ US$9.0227.0% of flowCommon StockSEC:0001104659-24-093503:0
2,274 shares@ US$5.8422.3% of flowCommon StockSEC:0001104659-24-065645:0
80,300 shares0Common StockSEC:0001104659-24-027724:0
About Nayak Sanjay
Nayak Sanjay is Chief Strategy Officer at OCULAR THERAPEUTIX, INC and Ocular Therapeutix, INC. He has filed 12 disclosures in total, and in the recent filings available from 2024-02-26 to 2026-02-25, they show only sales for a total of EUR 197190.